Prostate cancer patients who have a prostate-specific antigen value of less than or equal to 1.5 at two years after external beam radiation therapy are less likely to have a cancer recurrence and cancer-related death, according to a new study.
PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients
December 7th, 2009 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.